KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Gains from Investment Securities (2017 - 2025)

Alnylam Pharmaceuticals' Gains from Investment Securities history spans 15 years, with the latest figure at -$6.4 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 18.04% year-over-year to -$6.4 million; the TTM value through Dec 2025 reached $2.2 million, down 76.9%, while the annual FY2025 figure was $2.2 million, 76.9% down from the prior year.
  • Gains from Investment Securities reached -$6.4 million in Q3 2025 per ALNY's latest filing, down from -$1.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $9.8 million in Q1 2025 to a low of -$7.8 million in Q3 2024.
  • Average Gains from Investment Securities over 5 years is $1.5 million, with a median of $469500.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 3130.3% in 2022, then plummeted 275.6% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$165000.0 in 2021, then tumbled by 2361.82% to -$4.1 million in 2022, then surged by 209.26% to $4.4 million in 2023, then soared by 109.76% to $9.3 million in 2024, then crashed by 168.61% to -$6.4 million in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Gains from Investment Securities are -$6.4 million (Q3 2025), -$1.3 million (Q2 2025), and $9.8 million (Q1 2025).